Drips, the founders of Conversational Texting, has secured a growth investment from the Blue Venture Fund to support the company’s vision of enabling healthcare organizations to connect with their members and patients during critical moments through its conversational AI platform. This investment follows the previously announced investment from leading software investor Accel-KKR and its credit facility with Wells Fargo Capital Finance’s Technology Finance group.
The Blue Venture Fund is a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association (BCBSA), and Sandbox to which thirty-five BCBS companies have committed over $890 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield Plans and provides the portfolio with access to BCBS companies to deploy innovation at scale. Sandbox is an independent venture capital firm that provides healthcare-related investment management exclusively for the Blue Venture Fund.
Drips continues to drive value in the healthcare industry with its conversational AI platform. Clients in the healthcare vertical have a critical need to communicate with their members and patients in an automated, humanized way regarding health insurance policies, care coordination, Medicare options and more. The company’s Conversational Texting® technology enables these organizations to engage with their audience in a way that better aligns with their members’ preferences.
